Page last updated: 2024-08-05 13:15:08

trifluorobenzene

Any member of the class of fluorobenzenes carrying three fluorine substituents at unspecified positions.

ChEBI ID: 83576

Members (4)

MemberDefinitionRole
atogepantA secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine.atogepant
bictegravirA monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid with the amino group of 2,4,6-trifluorobenzylamine. It is a second-generation integrase strand transfer inhibitor (INSTI) and used (as its sodium salt) for the treatment of HIV-1.bictegravir
fluxapyroxadAn aromatic amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of 3',4',5'-trifluorobiphenyl-2-amine. Used to control a number of cereal fungal pathogens including those belonging to the Ascomycetes, Basidiomycetes and Zygomycetes families.fluxapyroxad
sitagliptinA triazolopyrazine that exhibits hypoglycemic activity.sitagliptin

Research

Studies (332)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's17 (5.12)29.6817
2010's119 (35.84)24.3611
2020's196 (59.04)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials44 (13.02%)5.53%
Reviews42 (12.43%)6.00%
Case Studies16 (4.73%)4.05%
Observational8 (2.37%)0.25%
Other228 (67.46%)84.16%